CYP3A
Br. J. Cancer 87 (6): 681–6. doi:10.1038/sj.bjc.6600494. PMC 2364247. PMID 12237780. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364247/.
Dowling TC, Briglia AE, Fink JC et al. (2003). “Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease”. Clin. Pharmacol. Ther. 73 (5): 427–34. doi:10.1016/S0009-9236(03)00056-0. PMID 12732843.
Sunman JA, Hawke RL, LeCluyse EL, Kashuba AD (2004). “Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes”. Drug Metab. Dispos. 32 (3): 359–63. doi:10.1124/dmd.32.3.359. PMID 14977871.
Somogyi AA, Menelaou A, Fullston SV (2005).